Selection of resistant fungi in liver transplant recipients during use of new anti-fungal agents

被引：0
|
作者：
Tan, Ban Hock [1 ]
Tan, Chee Kiat [1 ]
机构：
[1] Singapore Gen Hosp, Liver Transplant Serv, Singapore 0316, Singapore
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2008年 / 12卷
关键词：
D O I：
10.1016/S1201-9712(08)60024-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
22
引用
收藏
页码：S10 / S10
页数：1
相关论文
共 47 条
  • [31] Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis
    Gatti, Milo
    Rinaldi, Matteo
    Ferraro, Giuseppe
    Toschi, Alice
    Caroccia, Natascia
    Arbizzani, Federica
    Raschi, Emanuel
    Poluzzi, Elisabetta
    Pea, Federico
    Viale, Pierluigi
    Giannella, Maddalena
    MYCOSES, 2021, 64 (11) : 1317 - 1327
  • [32] IMMUNOSUPPRESSION THERAPY DURING TREATMENT OF CHRONIC HCV INFECTION WITH NEW ANTIVIRAL DRUGS IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS
    Musialik, Joanna
    Kolonko, Aureliusz
    Karkoszka, Henryk
    Kwiecien, Katarzyna
    JeDrusik, Ewa
    Wiecek, Andrzej
    TRANSPLANT INTERNATIONAL, 2017, 30 : 232 - 233
  • [33] TREND OF RENAL FUNCTION IN LIVER TRANSPLANT RECIPIENTS TREATED FOR CHRONIC HEPATITIS C VIRUS INFECTION WITH NEW DIRECT ACTING ANTIVIRAL AGENTS
    Nath, Anand
    Albers, Christopher
    Syed, Rashid Z.
    Agrawal, Saurabh
    Kemmer, Nyingi
    GASTROENTEROLOGY, 2018, 154 (06) : S1150 - S1150
  • [34] Fungal colonization, emergence of resistant strains, and breakthrough invasive fungal infections during antifungal prophylaxis with micafungin in patients with leukaemia and stem cell transplant recipients. A retrospective single centre analysis
    Nachbaur, D.
    Angelova, O.
    Orth, D.
    Ditlbacher, A.
    Lass-Floerl, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S326 - S326
  • [35] Daptomycin Perioperative Prophylaxis for Prevention of Vancomycin-Resistant Enterococcus Infection in VRE-Colonized Liver Transplant Recipients during the Early Post-Transplant Period.
    Sarwar, S.
    Gleeson, S.
    Malinis, M.
    Azar, M. M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 733 - 734
  • [36] Use of Anti-Interleukin-1 Agents in Kidney Transplant Recipients with Familial Mediterranean Fever and Amyloidosis: What have been Learned so Far?
    Afsar, Baris
    Afsar, Rengin Elsurer
    Caliskan, Yasar
    Lentine, Krista L.
    CURRENT TRANSPLANTATION REPORTS, 2025, 12 (01)
  • [37] Use of T Cell Mediated Immune Functional Assays for Adjustment of Immunosuppressive or Anti-infective Agents in Solid Organ Transplant Recipients: A Systematic Review
    Rezahosseini, Omid
    Moller, Dina Leth
    Knudsen, Andreas Dehlbaek
    Sorensen, Soren Schwartz
    Perch, Michael
    Gustafsson, Finn
    Rasmussen, Allan
    Ostrowski, Sisse Rye
    Nielsen, Susanne Dam
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [38] RISK OF CLINICALLY SIGNIFICANT BACTEREMIA AFTER ERCP IN LIVER TRANSPLANT RECIPIENTS IS LOW AND IS UNAFFECTED BY ROUTINE USE OF PROPHYLACTIC ANTI-MICROBIAL THERAPY
    Kohli, Divyanshoo R.
    Vachhani, Ravi
    Shah, Tilak
    Bouhaidar, Doumit
    Siddiqui, Mohammad S.
    GASTROENTEROLOGY, 2017, 152 (05) : S1127 - S1127
  • [39] IMPACT OF HEPATITIS C TREATMENT ON SURVIVAL OUTCOMES AMONG LIVER TRANSPLANT RECIPIENTS WITH RECURRENT INFECTION IN THE ERA OF DIRECT-ACTING ANTI-VIRAL AGENTS
    Latt, Nyan L.
    Mousa, Omar
    Aqel, Bashar
    Leise, Michael D.
    Keaveny, Andrew
    Pungpapong, Surakit
    GASTROENTEROLOGY, 2017, 152 (05) : S1058 - S1058
  • [40] Impact of Induction Immunosuppression Selection on Clinical Outcomes in Kidney Transplant Recipients During the COVID-19 Pandemic in New York City
    Khalil, K.
    Jonchhe, S.
    Stern, J.
    Lewis, T. C.
    Alnazari, N.
    Lonze, B.
    Lewis, Z. Stewart
    Ali, N.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 672 - 673
12345